Adjuvant Gemcitabine plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase Iii Nrg Oncology/Gynecologic Oncology Group Study
AuthID
P-00V-T7A
P-00V-T7A